What does this research mean for the field?

The designed antimicrobial peptides Act-6 and Act 8-20, derived from Scarabaeidae cecropins, exhibit significant in vitro and in vivo antifungal activity against pathogenic yeasts, including inhibiting biofilm formation and reducing fungal load in disseminated candidiasis. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study aims to evaluate the antifungal efficacy of antimicrobial peptides Act-6 and Act 8-20 derived from scarabaeidae against pathogenic yeasts.

July 12, 2025Journal of FungiOpen Access

Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity

View Full Paper

Ask AI

Bookmark

Authors

MRMelissa RodríguezNew York City Department of Education LTLily Johanna Toro CFCarolina FiracativeUniversidad del Rosario

Discussion

Member takes

Overview

Randomized trial assesses antifungal effects of new peptides in murine candidiasis, suggesting novel treatment options.

Key Points

This study aims to evaluate the antifungal efficacy of antimicrobial peptides Act-6 and Act 8-20 derived from scarabaeidae against pathogenic yeasts.
Assessed in vitro and in vivo antifungal activity of Act-6 and Act 8-20 against eight yeast strains.
Evaluated effects on biofilm, morphogenesis, and cell morphology of Candida albicans.
Conducted experiments using a murine model of disseminated candidiasis.
Act-6 and Act 8-20 exhibited significant antifungal activity against reference strains of Candida and Cryptococcus.
The peptide treatment notably inhibited biofilm formation and altered cell morphology in C. albicans.
In vivo, the fungal load in mice treated with these AMPs significantly decreased.

Cite This Study

Rodríguez et al. (2025) studied this question.

synapsesocial.com/papers/6a6ea60ff44fa9f079dc4576 https://doi.org/10.3390/jof11070519

View Full Paper

Ask AI

Bookmark

July 12, 2025Journal of FungiOpen Access

Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity

View Full Paper

Ask AI

Bookmark

Authors

MRMelissa RodríguezNew York City Department of Education LTLily Johanna Toro CFCarolina FiracativeUniversidad del Rosario

Discussion

Member takes

Overview

Randomized trial assesses antifungal effects of new peptides in murine candidiasis, suggesting novel treatment options.

Key Points

This study aims to evaluate the antifungal efficacy of antimicrobial peptides Act-6 and Act 8-20 derived from scarabaeidae against pathogenic yeasts.
Assessed in vitro and in vivo antifungal activity of Act-6 and Act 8-20 against eight yeast strains.
Evaluated effects on biofilm, morphogenesis, and cell morphology of Candida albicans.
Conducted experiments using a murine model of disseminated candidiasis.
Act-6 and Act 8-20 exhibited significant antifungal activity against reference strains of Candida and Cryptococcus.
The peptide treatment notably inhibited biofilm formation and altered cell morphology in C. albicans.
In vivo, the fungal load in mice treated with these AMPs significantly decreased.

Cite This Study

Rodríguez et al. (2025) studied this question.

synapsesocial.com/papers/6a6ea60ff44fa9f079dc4576 https://doi.org/10.3390/jof11070519

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark